Zobrazeno 1 - 10
of 147
pro vyhledávání: '"A V Tyurina"'
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 8 (2024)
Despite a variety of lipid-lowering drugs, mostly pelleted, aimed at reducing low-density lipoprotein cholesterol and triglycerides, only a small number of patients achieve their target levels. The reasons are insufficient adherence to treatment, rar
Externí odkaz:
https://doaj.org/article/e21b417a94c64b7eafa7fb8bb1d3ccda
Autor:
A. V. Tyurina, N. E. Gaevskaya, I. A. Ivanova, A. V. Filippenko, N. D. Omel’chenko, A. A. Trufanova, M. P. Pogozhova, A. O. Anoprienko, Yu. V. Sizova, N. I. Pasyukova
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2, Pp 193-195 (2024)
The possibility of cholera importation into our country and the increase in the number of Vibrio cholerae strains that are resistant to antibacterial agents necessitate the development of alternative therapeutic and prophylactic biological products b
Externí odkaz:
https://doaj.org/article/52f32e8c3f9a45d891f2abf0c5ae4a81
Autor:
Andrey S. Levashov, Svetlana R. Zagidullina, Timur T. Valiev, Anna M. Stroganova, Dmitry A. Khochenkov, Vasiliy A. Grigorenko, Elena V. Mikhaylova, Elizaveta V. Tyurina, Marina V. Ryzhova, Serhii K. Horielyshev, Shavkat U. Kadirov, Vladimir G. Polyakov
Publikováno v:
Современная онкология, Vol 26, Iss 1, Pp 80-86 (2024)
Background. The experience of using the like-SJMB03 therapeutic program is presented. The aim of this study was to assess the potential possibility of reducing the dose of craniospinal and local radiation therapy in the standard and high-risk group p
Externí odkaz:
https://doaj.org/article/d4cdc49225de4bff9be340e59b4f0e13
Autor:
A. V. Tyurina, N. E. Gaevskaya, E. A. Sinel’nik, I. A. Ivanova, A. V. Filippenko, N. D. Omel’chenko, A. A. Trufanova, M. P. Pogozhova, A. O. Anoprienko, N. I. Pasyukova
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 4, Pp 160-162 (2024)
The spread of Vibrio cholerae strains with multiple antibiotic resistance necessitates the search for alternatives to antibiotics. Cholera bacteriophages can become such means.The aim of the work was to study the safety of a mixture of cholera bacter
Externí odkaz:
https://doaj.org/article/723e3a94ddf4459d8ded9e3d453ad141
Autor:
Andrey S. Levashov, Svetlana R. Zagidullina, Timur T. Valiev, Anna M. Stroganova, Dmitry A. Khochenkov, Vasiliy A. Grigorenko, Elena V. Mikhaylova, Elizaveta V. Tyurina, Marina V. Ryzhova, Serhii K. Horielyshev, Shavkat U. Kadyrov, Vladimir G. Polyakov
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 385-390 (2023)
During the last 30 years, unique international experience has been accumulated in the treatment of children with medulloblastoma, especially in the age group over 3 years. Evolutionary representations about one of the most well – known internationa
Externí odkaz:
https://doaj.org/article/52a0ae2dd1d845fd8299cbadacec997b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 143-150 (2023)
Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy and their effectiveness in outpatient clinical practice based on the results of a questionnaire of primary care physicians.Material and methods. The study was per
Externí odkaz:
https://doaj.org/article/37d179a1ea3a412c8ae7ca9c442b1d30
Autor:
Elena A. Klesareva, Olga I. Afanasieva, Ekaterina E. Sherstyuk, Narek A. Tmoyan, Oksana A. Razova, Aleksandra V. Tyurina, Marina I. Afanasieva, Marat V. Ezhov, Sergei N. Pokrovsky
Publikováno v:
Терапевтический архив, Vol 94, Iss 4, Pp 479-484 (2022)
Background. Hyperlipoproteinemia (a) is an independent and cause risk factor for atherosclerotic cardiovascular diseases (ASCVD). The correlation between lipoprotein (a) Lp(a) and inflammation in the vessel wall was actively studied during the past f
Externí odkaz:
https://doaj.org/article/891af57acb694a51b9d879a179699733
Autor:
Olga I. Afanasieva, Alexandra V. Tyurina, Marat V. Ezhov, Oxana A. Razova, Elena A. Klesareva, Sergei N. Pokrovsky
Publikováno v:
Diseases, Vol 11, Iss 4, p 145 (2023)
Background. Lipoprotein(a) (Lp(a)) is a genetic risk factor of atherosclerotic cardiovascular diseases (ASCVDs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is related to vascular inflammation and detected in atherosclerotic plaques. A temp
Externí odkaz:
https://doaj.org/article/a8c3b2d17c1a45dd885c87ce0a748256
Autor:
A. V. Tyurina, O. I. Afanas’eva, E. A. Klesareva, N. A. Tmoyan, O. A. Razova, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 6 (2022)
Aim. To assess the relationship between premature coronary artery disease (CAD) and various lipid parameters.Material and methods. This retrospective longitudinal study included 166 men aged 57±9 years with coronary CAD with onset before age of 55.
Externí odkaz:
https://doaj.org/article/07ddb3049dcb47e1a9601d56b8d86d3a
Autor:
A. Yu. Filatova, O. I. Afanasieva, T. I. Arefieva, E. A. Klesareva, A. V. Tyurina, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 6 (2022)
Aim. To analyze the relationship of blood lipid profile parameters, including the level of lipoprotein(a) (Lp(a)), and the content of circulating CD4+ T-lymphocytes with premature coronary artery disease (CAD).Material and methods. This retrospective
Externí odkaz:
https://doaj.org/article/fb81eab07c2543e0ad6b10afc15b7d60